The Swiss Association against Osteoporosis (Association Suisse contre l'Ostéoporose [ASCO], Schweizerische Vereinigung gegen die Osteoprorose [SVGO]) was founded in 1989 with the primary aim to bring together the specialists of various fields, i.e. internal medicine, endocrinology, rheumatology, gynecology, orthopedic surgery, social- and preventive medicine, dealing with the problems of osteoporosis and to integrate the rapidly growing knowledge and progress on osteoporosis in a national consensus.

Introduction
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 11:45 a.m.
Romosozumab clinical data
Pr. Dr. B. Langdahl, Aarhus, DK
May 13, 2022 · 11:50 a.m.
116 views
Romosozumab limitation (CH): challenges and opportunities
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 12:25 p.m.
Questions & Answers Session
May 13, 2022 · 12:40 p.m.
Short- or long-term denosumab therapy? Part 1
Dr. J. Everts-Graber, Bern
May 13, 2022 · 1:37 p.m.
401 views
Short- or long-term denosumab therapy? Part 2
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 1:52 p.m.
Vitamin D: when to measure, what supplement?
Prof. Dr. H. Bischoff-Ferrari, Zürich
May 13, 2022 · 2:13 p.m.
Dietary calcium intake : How much, from where, for whom?
Dr. M. Papagiorgeou, Geneva
May 13, 2022 · 2:42 p.m.
Treatment of bone fragility in CRF
Pr.Dr O. Lamy, Lausanne
May 13, 2022 · 3:27 p.m.
Osteoporosis treatment after AFF and ONJ
Dr. PD E Biver, Geneva
May 13, 2022 · 3:55 p.m.